Literature DB >> 10516666

Influence of endothelins and sarafotoxin 6c and L-NAME on renal vasoconstriction in the anaesthetized rat.

J L Marshall1, E J Johns.   

Abstract

1. An investigation was performed in pentobarbitone anaesthetized rats to compare the renal vasoconstrictor actions of endothelin-1 (ET-1), endothelin-3 (ET-3) and sarafotoxin 6c and their dependency on NO production. 2. Intra-renal arterial infusion of ET-1 and ET-3, from 1 - 1000 ng had no effect on blood pressure, but reduced renal blood flow maximally by 82 and 81% with EC50 values of 510+/-18 and 1113+/-17 ng, respectively and correspondingly increased renal vascular resistance and decreased conductance. 3. Direct renal arterial administration of sarafotoxin 6c was without effect on blood pressure but caused a maximum reduction in renal blood flow of 56% at 300 ng and had an EC50 of 86+/-4 ng. 4. Administration of the selective ETA receptor antagonist FR139317 at 0.3 and 1.0 mg kg-1 had no effect on basal levels of blood pressure, renal vascular resistance or renal blood flow. The lower dose of FR139317 had no effect on the ET-1 dose-response curve for renal blood flow while at 1.0 mg kg-1, FR139317 reduced the EC50 to 363+/-32 ng (P<0.05). 5. Infusion of L-NAME, 10 microg kg-1 min-1 increased blood pressure by approximately 15%, increased renal vascular resistance and decreased renal blood flow by some 40%. The EC50 values for renal blood flow were reduced to 358+/-68 ng (P<0.05) for ET-1, 638+/-69 ng (P<0.05) for ET-3 and 55+/-10 ng (P<0.01) for sarafotoxin 6c. The maximal reduction in renal blood flow induced by sarafotoxin 6c was raised (P<0.01) from 56% to approximately 100% and renal vascular resistance increased when NO production was blocked. 6. These results showed that the vasoconstrictor actions of ET-1 and ET-3 on resistance vessels controlling renal blood flow are mediated via ETB rather than ETA receptors. Moreover, both ET-1 and ET-3 dependent vasoconstrictions are slightly attenuated by concomitant NO production. By contrast, sarafotoxin 6c appears much more potent at the renal resistance vasculature and is much more powerfully modulated by NO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516666      PMCID: PMC1571686          DOI: 10.1038/sj.bjp.0702846

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Influence of ETR-p1/f1 antisense peptide on endothelin-induced constriction in rat renal arcuate arteries.

Authors:  X Wu; N T Richards; E J Johns; T Kohsaka; A Nakamura; H Okada
Journal:  Br J Pharmacol       Date:  1997-09       Impact factor: 8.739

2.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

Review 3.  Endothelin peptides and the kidney.

Authors:  M S Simonson; M J Dunn
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

4.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

5.  Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.

Authors:  J P Cristol; T D Warner; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction.

Authors:  M J Sumner; T R Cannon; J W Mundin; D G White; I S Watts
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

7.  Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation.

Authors:  D M Pollock; T J Opgenorth
Journal:  Am J Physiol       Date:  1993-01

8.  Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.

Authors:  K Sogabe; H Nirei; M Shoubo; A Nomoto; S Ao; Y Notsu; T Ono
Journal:  J Pharmacol Exp Ther       Date:  1993-03       Impact factor: 4.030

9.  Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes.

Authors:  D L Williams; K L Jones; D J Pettibone; E V Lis; B V Clineschmidt
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

10.  Endothelin and structurally related analogs distinguish between endothelin receptor subtypes.

Authors:  R L Panek; T C Major; G P Hingorani; A M Doherty; D G Taylor; S T Rapundalo
Journal:  Biochem Biophys Res Commun       Date:  1992-03-16       Impact factor: 3.575

View more
  2 in total

1.  The acute pressure natriuresis response is suppressed by selective ETA receptor blockade.

Authors:  Geoffrey Culshaw; David Binnie; Neeraj Dhaun; Patrick Hadoke; Matthew Bailey; David J Webb
Journal:  Clin Sci (Lond)       Date:  2021-12-17       Impact factor: 6.124

2.  Effects of cyclic intermittent hypoxia on ET-1 responsiveness and endothelial dysfunction of pulmonary arteries in rats.

Authors:  Zhuo Wang; Ai-Ying Li; Qiu-Hong Guo; Jian-Ping Zhang; Qi An; Ya-jing Guo; Li Chu; J Woodrow Weiss; En-Sheng Ji
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.